Page 20 - Read Online

D, Zeng M, Song E. A cytoplasmic NF-kappaB interacting long deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell
noncoding RNA blocks IkappaB phosphorylation and suppresses 2013;49:1083-96.
breast cancer metastasis. Cancer Cell 2015;27:370-81. 73. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in
64. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB. tumour progression: an alliance against the epithelial phenotype?
NF-kappaB addiction and its role in cancer: ‘one size does not fit Nat Rev Cancer 2007;7:415-28.
all’. Oncogene 2011;30:1615-30. 74. Nissan A, Stojadinovic A, Mitrani-Rosenbaum S, Halle D, Grinbaum
65. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell R, Roistacher M, Bochem A, Dayanc BE, Ritter G, Gomceli I,
2002;109 Suppl: S81-96. Bostanci EB, Akoglu M, Chen YT, Old LJ, Gure AO. Colon cancer
66. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal associated transcript-1: a novel RNA expressed in malignant and
transitions in development and disease. Cell 2009;139:871-90. pre-malignant human tissues. Int J Cancer 2012;130:1598-606.
67. Akhurst RJ, Hata A. Targeting the TGFbeta signalling pathway in 75. Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y, Fang G. Long
disease. Nat Rev Drug Discov 2012;11:790-811. noncoding RNA CCAT1, which could be activated by c-Myc,
68. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor promotes the progression of gastric carcinoma. J Cancer Res Clin
and pro-metastatic factor in human cancer. Biochim Biophys Acta Oncol 2013;139:437-45.
2007;1775:21-62. 76. Deng L, Yang SB, Xu FF, Zhang JH. Long noncoding RNA CCAT1
69. Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, Liu F, Pan promotes hepatocellular carcinoma progression by functioning as
W, Wang TT, Zhou CC, Wang SB, Wang YZ, Yang Y, Yang N, let-7 sponge. J Exp Clin Cancer Res 2015;34:18.
Zhou WP, Yang GS, Sun SH. A long noncoding RNA activated by 77. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in
TGF-beta promotes the invasion-metastasis cascade in hepatocellular cancer biology. Cancer Discov 2011;1:391-407.
carcinoma. Cancer Cell 2014;25:666-81. 78. Winkle M, van den Berg A, Tayari M, Sietzema J, Terpstra M,
70. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Kortman G, de Jong D, Visser L, Diepstra A, Kok K, Kluiver
Spaderna S, Brabletz T. A reciprocal repression between ZEB1 and J. Long noncoding RNAs as a novel component of the Myc
members of the miR-200 family promotes EMT and invasion in transcriptional network. FASEB J 2015;29:2338-46.
cancer cells. EMBO Rep 2008;9:582-9. 79. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier
71. Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, Zhu N, Zhou E. A programmable dual-RNA-guided DNA endonuclease in
WP, Yang GS, Wang YZ, Shang JL, Gao CF, Zhang FR, Wang F, adaptive bacterial immunity. Science 2012;337:816-21.
Sun SH. Long noncoding RNA high expression in hepatocellular 80. Sanchez-Rivera FJ, Jacks T. Applications of the CRISPR-Cas9
carcinoma facilitates tumor growth through enhancer of zeste system in cancer biology. Nat Rev Cancer 2015;15:387-95.
homolog 2 in humans. Hepatology 2011;54:1679-89. 81. Ho TT, Zhou N, Huang J, Koirala P, Xu M, Fung R, Wu F, Mo
72. Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP, Wang F, Sun YY. Targeting non-coding RNAs with the CRISPR/Cas9 system in
SH. Repression of the long noncoding RNA-LET by histone human cell lines. Nucleic Acids Res 2015;43:e17.

10
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ Issue 1 ¦ January 15, 2016 ¦